Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2026-01-07 @ 9:54 PM
Study NCT ID:
NCT03258593
Status:
COMPLETED
Last Update Posted:
2025-12-19
First Post:
2017-08-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
Sponsor:
National Cancer Institute (NCI)
Organization: